Caspofungin 50 mg powder for concentrate for solution for infusion
*Company:
Flynn Pharma LtdStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 02 February 2023
File name
SmpC 50mg 2023 01 30.pdf
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 5.1 - Pharmacodynamic properties
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Update in line with reference product
Updated on 23 August 2022
File name
ie-pil-mockup 50mg 2022 05 05.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
Updated on 23 August 2022
File name
SmPC 50mg 2022 05 05.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 07 April 2021
File name
SmPC 50mg 2021 03 26.pdf
Reasons for updating
- Change to section 9 - Date of first authorisation/renewal of the authorisation
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Addition of renewal date. No other changes made to the SmPC
Updated on 19 January 2021
File name
Caspofungin PIL 50mg 2018.pdf
Reasons for updating
- New PIL for new product
Updated on 19 January 2021
File name
Caspofungin SmPC 50mg 2018.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)